Bailard’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-293,000
| Closed | -$2.37M | – | 556 |
|
|
2020
Q2 | $2.37M | Buy |
293,000
+203,000
| +226% | +$1.64M | 0.13% | 129 |
|
|
2020
Q1 | $715K | Buy |
+90,000
| New | +$715K | 0.05% | 197 |
|
|
2018
Q1 | – | Sell |
-141,000
| Closed | -$1.16M | – | 471 |
|
|
2017
Q4 | $1.16M | Hold |
141,000
| – | – | 0.07% | 224 |
|
|
2017
Q3 | $1.48M | Hold |
141,000
| – | – | 0.11% | 145 |
|
|
2017
Q2 | $1.56M | Hold |
141,000
| – | – | 0.13% | 150 |
|
|
2017
Q1 | $1.37M | Buy |
+141,000
| New | +$1.37M | 0.11% | 155 |
|
|
2016
Q4 | – | Sell |
-120,700
| Closed | -$1.5M | – | 305 |
|
|
2016
Q3 | $1.5M | Buy |
120,700
+17,700
| +17% | +$220K | 0.14% | 138 |
|
|
2016
Q2 | $1.11M | Buy |
+103,000
| New | +$1.11M | 0.13% | 151 |
|
|
2015
Q3 | – | Sell |
-155,000
| Closed | -$3.28M | – | 248 |
|
|
2015
Q2 | $3.28M | Sell |
155,000
-90,000
| -37% | -$1.91M | 0.51% | 31 |
|
|
2015
Q1 | $4.41M | Buy |
245,000
+110,000
| +81% | +$1.98M | 0.61% | 21 |
|
|
2014
Q4 | $2.31M | Sell |
135,000
-100,000
| -43% | -$1.71M | 0.33% | 51 |
|
|
2014
Q3 | $3.36M | Hold |
235,000
| – | – | 0.52% | 31 |
|
|
2014
Q2 | $3.53M | Buy |
235,000
+175,000
| +292% | +$2.63M | 0.54% | 29 |
|
|
2014
Q1 | $804K | Buy |
+60,000
| New | +$804K | 0.13% | 99 |
|